Skip to search formSkip to main contentSkip to account menu

UK 294,315

Known as: UK294315, UK-294315, UK 294315 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315.
The objective of the study was to use the combined approach of gamma scintigraphy and pharmacokinetics, in order to understand… 
2008
2008
In Vivo Performance of an Oral MR Matrix Tablet Formulation in the Beagle Dog in the Fed and Fasted State: Assessment of Mechanical Weakness
PurposeTo evaluate the behaviour of an oral matrix modified release formulation in the canine gastrointestinal tract, and… 
2004
2004
Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to…
4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline (UK-294,315) is an… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)